126 related articles for article (PubMed ID: 1848233)
1. Preferential coupling of cell surface muscarinic receptors to phosphoinositide hydrolysis in human neuroblastoma cells.
Thompson AK; Fisher SK
J Biol Chem; 1991 Mar; 266(8):5004-10. PubMed ID: 1848233
[TBL] [Abstract][Full Text] [Related]
2. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
Fisher SK
Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
[TBL] [Abstract][Full Text] [Related]
3. The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation.
Thompson AK; Mostafapour SP; Denlinger LC; Bleasdale JE; Fisher SK
J Biol Chem; 1991 Dec; 266(35):23856-62. PubMed ID: 1660886
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor regulation of cytoplasmic Ca2+ concentrations in human SK-N-SH neuroblastoma cells: Ca2+ requirements for phospholipase C activation.
Fisher SK; Domask LM; Roland RM
Mol Pharmacol; 1989 Feb; 35(2):195-204. PubMed ID: 2537457
[TBL] [Abstract][Full Text] [Related]
5. Organophosphate-induced alterations in muscarinic receptor binding and phosphoinositide hydrolysis in the human SK-N-SH cell line.
Katz LS; Marquis JK
Neurotoxicology; 1992; 13(2):365-78. PubMed ID: 1331918
[TBL] [Abstract][Full Text] [Related]
6. Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations.
Thompson AK; Fisher SK
J Pharmacol Exp Ther; 1990 Feb; 252(2):744-52. PubMed ID: 2156059
[TBL] [Abstract][Full Text] [Related]
7. Reduction of muscarinic receptor density and of guanine nucleotide-stimulated phosphoinositide hydrolysis in human SH-SY5Y neuroblastoma cells following long-term treatment with 12-O-tetradecanoylphorbol 13-acetate or mezerein.
Cioffi CL; Fisher SK
J Neurochem; 1990 May; 54(5):1725-34. PubMed ID: 2157816
[TBL] [Abstract][Full Text] [Related]
8. SK & F 96365 inhibits carbachol-induced phosphoinositide turnover in human neuroblastoma SH-SY5Y and rat cerebellar granule cells.
Lin WW; Wang CW
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):53-8. PubMed ID: 8832588
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced desensitization of cholinergically stimulated phosphoinositide breakdown is independent of endogenously activated protein kinase C in HT-29 human colon carcinoma cells.
Kopp R; Mayer P; Pfeiffer A
Biochem J; 1990 Jul; 269(1):73-8. PubMed ID: 2165399
[TBL] [Abstract][Full Text] [Related]
10. Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis.
Masters SB; Quinn MT; Brown JH
Mol Pharmacol; 1985 Mar; 27(3):325-32. PubMed ID: 2983182
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic receptors coupled to phosphoinositide hydrolysis and elevated cytosolic calcium in a human neuroblastoma cell line SK-N-SH.
Baird JG; Lambert DG; McBain J; Nahorski SR
Br J Pharmacol; 1989 Dec; 98(4):1328-34. PubMed ID: 2558760
[TBL] [Abstract][Full Text] [Related]
12. A rapid attenuation of muscarinic agonist stimulated phosphoinositide hydrolysis precedes receptor sequestration in human SH-SY-5Y neuroblastoma cells.
Fisher SK; Slowiejko DM; McEwen EL
Neurochem Res; 1994 May; 19(5):549-54. PubMed ID: 8065510
[TBL] [Abstract][Full Text] [Related]
13. The epithelial phenotype of human neuroblastoma cells express bradykinin, endothelin, and angiotensin II receptors that stimulate phosphoinositide hydrolysis.
Ogino Y; Costa T
J Neurochem; 1992 Jan; 58(1):46-56. PubMed ID: 1309239
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
[TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of phorbol ester and agonist-mediated activation of protein kinase C on phosphoinositide and Ca2+ signalling in a human neuroblastoma.
Willars GB; Challiss RA; Stuart JA; Nahorski SR
Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):905-13. PubMed ID: 8670170
[TBL] [Abstract][Full Text] [Related]
16. Antagonism by 8-hydroxy-2(di-n-propylamino)tetraline and other serotonin agonists of muscarinic M1-type receptors coupled to inositol phospholipid breakdown in human IMR-32 and SK-N-MC neuroblastoma cells.
Fowler CJ; Ahlgren PC; O'Neill C
Life Sci; 1991; 48(10):959-67. PubMed ID: 1825686
[TBL] [Abstract][Full Text] [Related]
17. Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
Fisher SK; Snider RM
Mol Pharmacol; 1987 Jul; 32(1):81-90. PubMed ID: 3600615
[TBL] [Abstract][Full Text] [Related]
18. A comparison between muscarinic receptor occupancy, inositol 1,4,5-trisphosphate accumulation and Ca2+ mobilization in permeabilized SH-SY5Y neuroblastoma cells.
Safrany ST; Nahorski SR
Neuropharmacology; 1994 Jul; 33(7):837-46. PubMed ID: 7969802
[TBL] [Abstract][Full Text] [Related]
19. Studies of muscarinic receptor reserve linked to phosphoinositide hydrolysis in parotid gland and cerebral cortex.
Ek B; Antonsson BM
Acta Physiol Scand; 1993 Mar; 147(3):289-95. PubMed ID: 8386426
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological differences between muscarinic receptors coupled to phosphoinositide turnover and those coupled to adenylate cyclase inhibition.
Baumgold J; White T
Biochem Pharmacol; 1989 May; 38(10):1605-16. PubMed ID: 2471534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
